AFRICA: Malaria vaccine could make major difference
You must be signed in to read this analysis
In this article
- Existing strategy limits
- Antimalarial drugs
- Vector control
- Limiting exposure
- Zambian example
- Vaccine science
- Complexity
- Evolution
- Substrains
- Resistance
- Economic barriers
- Vaccine initiatives
- SPf66
- RTS,S/AS02A
- Sanaria
- Others
- Outlook
- Partial efficacy
- Wait time
- Funding
- Take-up
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.